Abilita Bio

BiotechnologySeedSan Diego, USabilitabio.com

Latest round

Seed

Last raised

Dec 2022

Total raised

$7.5M

Investors

1

About Abilita Bio

Based in California, US, and founded by Mauro Mileni (CEO) in 2014, Abilita Bio, Inc. operates as a biotechnology company specializing in the discovery and development of small molecule therapeutics. The company focuses on the discovery and development of drugs targeting specific disease-associated membrane proteins including G Protein-Coupled Receptors (GPCRs) and ion channels to develop therapies for various diseases including cancer, fibrosis, and immunological disorders. The company’s lead program is focused on developing a small molecule inhibitor for the treatment of triple-negative breast cancer through EMP™ (enabled membrane proteins) technology. The other list of target therapies in the pipeline by Abilita is GPCR1 targeting immune-oncology and GPCR2 oncology in optimization state as of March 2023, and Ion Channel 1 and 2 for pain in the discovery stage.

Who invested in Abilita Bio

1 investor across 1 round

See all investors in Abilita Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Dec 9, 2022

    Amount

    $7.5M

    Investors

    Locked

Questions about Abilita Bio

Who invested in Abilita Bio?

Abilita Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Abilita Bio raised?

Abilita Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Abilita Bio last raise money?

Abilita Bio's most recent round on record is a Seed, in Dec 2022.

What does Abilita Bio do?

Based in California, US, and founded by Mauro Mileni (CEO) in 2014, Abilita Bio, Inc.

Where is Abilita Bio headquartered?

Abilita Bio is headquartered in San Diego, US.

Which VCs invest in companies like Abilita Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Abilita Bio's stage. Their profiles are linked below.

Raising like Abilita Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.